Journal of Modern Oncology
ISSN 1815-1434 (Print)
ISSN 1815-1442 (Online)
Menu
Archives
Home
About the Journal
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Archives
Contact
Editorial board
OmniDoctor
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
×
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Home
>
Search
>
Author Details
Author Details
Semiglazov, V F
Issue
Section
Title
File
Vol 3, No 1 (2001)
Articles
Novoe v terapii raka molochnoy zhelezy: neoad\"yuvantnaya gormonoterapiya
Vol 5, No 3 (2003)
Articles
Novyy vzglyad na neoad\"yuvantnuyu khimioterapiyu raka molochnoy zhelezy (rol' navel'bina)
Vol 5, No 4 (2003)
Articles
Arimideks (anastrozol) v sravnenii s tamoksifenom v neoad\"yuvantnoy endokrinoterapii bol'nykh rakom molochnoy zhelezy
Vol 7, No 1 (2005)
Articles
Faktory prognoza pri rake molochnoy zhelezy
Vol 7, No 1 (2005)
Articles
Znachenie taksanov v neoad\"yuvantnoy terapii raka molochnoy zhelezy
Vol 7, No 2 (2005)
Articles
«Problema optimizatsii ad\"yuvantnoy endokrinnoy terapii na rannikh stadiyakh raka molochnoy zhelezy»
Vol 9, No 2 (2007)
Articles
Ad\"yuvantnaya endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
Vol 11, No 3 (2009)
Articles
Predoperatsionnaya (neoad\"yuvantnaya) endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
Vol 15, No 4 (2013)
Articles
The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
Vol 16, No 2 (2014)
Articles
Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board
Vol 16, No 4 (2014)
Articles
Male breast cancer: review of the literature
Vol 17, No 1 (2015)
Articles
The improvement in overall survival for patients with metastatic breast cancer treated with eribulin: the resolution based on results of the expert council
Vol 17, No 1 (2015)
Articles
Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer
Vol 18, No 2 (2016)
Articles
New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer
(Rus)
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP